150 related articles for article (PubMed ID: 34819963)
1. Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography.
Boeder NF; Dörr O; Gaderer R; Blachutzik F; Achenbach S; Elsässer A; Hamm C; Nef HM
Postepy Kardiol Interwencyjnej; 2021 Sep; 17(3):272-280. PubMed ID: 34819963
[TBL] [Abstract][Full Text] [Related]
2. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
3. Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario.
Boeder NF; Dörr O; Koepp T; Blachutzik F; Achenbach S; Elsässer A; Hamm CW; Nef HM
Front Cardiovasc Med; 2021; 8():696287. PubMed ID: 34195239
[No Abstract] [Full Text] [Related]
4. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
[TBL] [Abstract][Full Text] [Related]
5. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.
Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM
Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853
[TBL] [Abstract][Full Text] [Related]
6. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
7. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
[TBL] [Abstract][Full Text] [Related]
8. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
[TBL] [Abstract][Full Text] [Related]
9. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Tröbs M; Röther J; Schlundt C; Achenbach S; Hamm C; Nef H
Heart Vessels; 2017 Jul; 32(7):781-789. PubMed ID: 28004176
[TBL] [Abstract][Full Text] [Related]
10. Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.
Okamoto N; Ueda H; Yoshimura T; Chamaria S; Bhatheja S; Vengrenyuk Y; Rabiei S; Barrientos Y; Kapur V; Barman N; Sweeny J; Baber U; Mehran R; Sharma SK; Kini AS
J Invasive Cardiol; 2018 Jul; 30(7):251-255. PubMed ID: 29656280
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation.
Baquet M; Brenner C; Wenzler M; Eickhoff M; David J; Brunner S; Theiss H; Massberg S; Guagliumi G; Mehilli J
J Interv Cardiol; 2017 Feb; 30(1):16-23. PubMed ID: 27896843
[TBL] [Abstract][Full Text] [Related]
12. Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage.
Giblett JP; Brown AJ; Keevil H; Jaworski C; Hoole SP; West NE
EuroIntervention; 2016 Aug; 12(6):724-33. PubMed ID: 27542784
[TBL] [Abstract][Full Text] [Related]
13. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
[TBL] [Abstract][Full Text] [Related]
14. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
[TBL] [Abstract][Full Text] [Related]
15. Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.
Mattesini A; Boeder N; Valente S; Löblich K; Dörr O; Secco GG; Foin N; Caiazzo G; Ghione M; Gensini GF; Porto I; Di Mario C; Nef H
EuroIntervention; 2016 Aug; 12(5):e566-73. PubMed ID: 27497356
[TBL] [Abstract][Full Text] [Related]
16. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ
Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380
[TBL] [Abstract][Full Text] [Related]
17. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
Gomez-Lara J; Diletti R; Brugaletta S; Onuma Y; Farooq V; Thuesen L; McClean D; Koolen J; Ormiston JA; Windecker S; Whitbourn R; Dudek D; Dorange C; Veldhof S; Rapoza R; Regar E; Garcia-Garcia HM; Serruys PW
EuroIntervention; 2012 Jun; 8(2):214-24. PubMed ID: 22030265
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
19. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
20. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis.
Diletti R; van der Sijde J; Karanasos A; Fam JM; Felix C; van Mieghem NM; Regar E; Rapoza R; Zijlstra F; van Geuns RJ
Int J Cardiol; 2016 Oct; 220():802-8. PubMed ID: 27394977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
